Teva Pharmaceutical Industries Ltd - Company Profile
Powered by 
All the data and insights you need on Teva Pharmaceutical Industries Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Teva Pharmaceutical Industries Ltd Strategy Report
- Understand Teva Pharmaceutical Industries Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Teva Pharmaceutical Industries Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Teva Pharmaceutical Industries Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Sol J. Barer, Ph.D.
Chairman Executive BoardDr. Sol J. Barer has been the Chairman of the company since 2017. Prior to this, he served on the Board of Directors of Contrafect. Previously, he served as the Chairman of NexImmune Inc. Dr. Barer served as the founder of the biotechnology group at the chemical company Celanese Corp. Currently, he also serves as the Managing Partner of SJ Barer Consulting and Advisor to the Israel Biotech Fund.
Richard D. Francis
Director; President; Chief Executive Officer Executive BoardMr. Richard D. Francis has been the President, Chief Executive Officer and Director of the company since January 2023. Prior to this, he served as the Chief Executive Officer of Purespring Therapeutics. Mr. Francis also served as the Chief Executive Officer of Forcefield Therapeutics. Previously, he served as the Chief Executive Officer of Sandoz.
Eli Kalif
Chief Financial Officer; Executive Vice President Senior ManagementMr. Eli Kalif has been the Executive Vice President and Chief Financial Officer of the company since 2019. Prior to this, he served as the Senior Vice President, Finance of Flex. Mr. Kalif also served as the Audit Manager at Deloitte.
David McAvoy
Executive Vice President; Chief Legal Officer Senior ManagementMr. David McAvoy has been the Executive Vice President and Chief Legal Officer of the company since March 2024. Prior to this, he served as the General Counsel and Chief Compliance Officer of Fresh Tracks Therapeutics. Previously, he served as the General Counsel and Chief Compliance Officer at Endocyte.
Eric A. Hughes, MD
Chief Medical Officer; Executive Vice President - Global R&D Senior ManagementMr. Eric A. Hughes, MD has been the Executive Vice President, Global R&D and Chief Medical Officer of the company since 2022. Prior to this, he served as the Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals. Mr. Hughes also served as the Head of the Immunology, Hepatology and Dermatology Global Development Unit of Novartis.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer